These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11397749)

  • 1. Extracts from "Clinical Evidence". Obesity.
    Arterburn D; Noël PH
    BMJ; 2001 Jun; 322(7299):1406-9. PubMed ID: 11397749
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of obesity with drugs.
    Hirsch J
    Am J Clin Nutr; 1998 Jan; 67(1):2-4. PubMed ID: 9440366
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug-clinics. The hue and cry over central appetite suppressants!].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348
    [No Abstract]   [Full Text] [Related]  

  • 4. Diet pills redux.
    Curfman GD
    N Engl J Med; 1997 Aug; 337(9):629-30. PubMed ID: 9271487
    [No Abstract]   [Full Text] [Related]  

  • 5. Aminorex fumarate: a double-blind trial and examination for signs of pulmonary arterial hypertension.
    Kew MC
    S Afr Med J; 1970 Apr; 44(14):421-3. PubMed ID: 4910309
    [No Abstract]   [Full Text] [Related]  

  • 6. Serious adverse reactions to anorectic agents.
    Thomas SH
    Adverse Drug React Toxicol Rev; 1998 Nov; 17(4):209-25. PubMed ID: 10196627
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe heart valve disease on appetite suppressants.
    Prescrire Int; 1998 Feb; 7(33):19-20. PubMed ID: 10183395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
    Goldstein SE; Levy Y; Shoenfeld Y
    Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The French are wary of their drugs].
    Nau JY
    Rev Med Suisse; 2011 May; 7(296):1170-1. PubMed ID: 21728251
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?].
    Godeau P; Cherin P; Tellier P
    Rev Med Interne; 1998 Oct; 19(10):700-3. PubMed ID: 9827440
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacotherapy for obesity -- do the benefits outweigh the risks?
    Manson JE; Faich GA
    N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523
    [No Abstract]   [Full Text] [Related]  

  • 12. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 13. Taking things to heart.
    Hess MA
    J Am Diet Assoc; 2004 Jul; 104(7):1073; author reply 1073-4. PubMed ID: 15215760
    [No Abstract]   [Full Text] [Related]  

  • 14. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?
    Voelkel NF; Clarke WR; Higenbottam T
    Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009
    [No Abstract]   [Full Text] [Related]  

  • 15. Obesity drugs and the heart.
    Connolly HM; McGoon MD
    Curr Probl Cardiol; 1999 Dec; 24(12):745-92. PubMed ID: 10609092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further cases of valvular heart disease associated with fenfluramine-phentermine.
    Graham DJ; Green L
    N Engl J Med; 1997 Aug; 337(9):635. PubMed ID: 9280830
    [No Abstract]   [Full Text] [Related]  

  • 17. Benfluorex: increasing reports of valve disorders.
    Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anorectic-induced valvulopathy.
    Cheng TO
    Eur Heart J; 2000 Apr; 21(7):593-4. PubMed ID: 10775015
    [No Abstract]   [Full Text] [Related]  

  • 19. Fen-phen manufacturers, not physicians, are liable.
    Allen S; Henderson J
    Tex Med; 2000 May; 96(5):62-4. PubMed ID: 10843016
    [No Abstract]   [Full Text] [Related]  

  • 20. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
    Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.